Annual Current Liabilities
$22.26 M
+$6.90 M+44.92%
December 31, 2023
Summary
- As of February 12, 2025, ALDX annual total current liabilities is $22.26 million, with the most recent change of +$6.90 million (+44.92%) on December 31, 2023.
- During the last 3 years, ALDX annual current liabilities has risen by +$9.85 million (+79.38%).
- ALDX annual current liabilities is now at all-time high.
Performance
ALDX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$17.15 M
-$10.44 M-37.84%
September 30, 2024
Summary
- As of February 12, 2025, ALDX quarterly total current liabilities is $17.15 million, with the most recent change of -$10.44 million (-37.84%) on September 30, 2024.
- Over the past year, ALDX quarterly current liabilities has dropped by -$4.46 million (-20.65%).
- ALDX quarterly current liabilities is now -37.84% below its all-time high of $27.59 million, reached on June 30, 2024.
Performance
ALDX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ALDX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.9% | -20.6% |
| 3 y3 years | +79.4% | +43.6% |
| 5 y5 years | +162.7% | +41.6% |
ALDX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +89.1% | -37.8% | +45.7% |
| 5 y | 5-year | at high | +89.1% | -37.8% | +251.0% |
| alltime | all time | at high | +6025.5% | -37.8% | +8434.0% |
Aldeyra Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.15 M(-37.8%) |
| Jun 2024 | - | $27.59 M(+27.3%) |
| Mar 2024 | - | $21.68 M(-2.6%) |
| Dec 2023 | $22.26 M(+44.9%) | $22.26 M(+3.0%) |
| Sep 2023 | - | $21.62 M(+38.5%) |
| Jun 2023 | - | $15.61 M(-2.5%) |
| Mar 2023 | - | $16.01 M(+4.2%) |
| Dec 2022 | $15.36 M(+30.5%) | $15.36 M(-36.5%) |
| Sep 2022 | - | $24.20 M(+49.0%) |
| Jun 2022 | - | $16.24 M(-0.7%) |
| Mar 2022 | - | $16.35 M(+38.9%) |
| Dec 2021 | $11.77 M(-5.1%) | $11.77 M(-1.4%) |
| Sep 2021 | - | $11.94 M(+61.2%) |
| Jun 2021 | - | $7.41 M(-33.2%) |
| Mar 2021 | - | $11.09 M(-10.6%) |
| Dec 2020 | $12.41 M(-3.9%) | $12.41 M(+92.1%) |
| Sep 2020 | - | $6.46 M(+31.3%) |
| Jun 2020 | - | $4.92 M(+0.7%) |
| Mar 2020 | - | $4.89 M(-62.1%) |
| Dec 2019 | $12.91 M(+52.3%) | $12.91 M(+6.5%) |
| Sep 2019 | - | $12.12 M(+89.6%) |
| Jun 2019 | - | $6.39 M(-32.7%) |
| Mar 2019 | - | $9.49 M(+12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $8.47 M(+152.7%) | $8.47 M(+10.7%) |
| Sep 2018 | - | $7.65 M(+44.1%) |
| Jun 2018 | - | $5.31 M(+44.8%) |
| Mar 2018 | - | $3.67 M(+9.3%) |
| Dec 2017 | $3.35 M(+45.9%) | $3.35 M(+38.6%) |
| Sep 2017 | - | $2.42 M(+14.6%) |
| Jun 2017 | - | $2.11 M(-12.3%) |
| Mar 2017 | - | $2.41 M(+4.8%) |
| Dec 2016 | $2.30 M(+8.7%) | $2.30 M(-12.8%) |
| Sep 2016 | - | $2.64 M(+11.1%) |
| Jun 2016 | - | $2.37 M(+31.3%) |
| Mar 2016 | - | $1.81 M(-14.5%) |
| Dec 2015 | $2.12 M(+59.3%) | $2.12 M(+53.9%) |
| Sep 2015 | - | $1.37 M(-1.2%) |
| Jun 2015 | - | $1.39 M(+34.3%) |
| Mar 2015 | - | $1.04 M(-21.9%) |
| Dec 2014 | $1.33 M(+119.4%) | $1.33 M(+56.9%) |
| Sep 2014 | - | $846.10 K(-28.0%) |
| Jun 2014 | - | $1.17 M(+69.8%) |
| Mar 2014 | - | $691.50 K(+14.3%) |
| Dec 2013 | $605.00 K(+66.5%) | $605.00 K(+201.0%) |
| Sep 2013 | - | $201.00 K(-44.7%) |
| Dec 2012 | $363.40 K(-86.0%) | $363.40 K |
| Dec 2011 | $2.59 M | - |
FAQ
- What is Aldeyra Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual current liabilities year-on-year change?
- What is Aldeyra Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly current liabilities year-on-year change?
What is Aldeyra Therapeutics annual total current liabilities?
The current annual current liabilities of ALDX is $22.26 M
What is the all time high annual current liabilities for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual total current liabilities is $22.26 M
What is Aldeyra Therapeutics annual current liabilities year-on-year change?
Over the past year, ALDX annual total current liabilities has changed by +$6.90 M (+44.92%)
What is Aldeyra Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ALDX is $17.15 M
What is the all time high quarterly current liabilities for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly total current liabilities is $27.59 M
What is Aldeyra Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ALDX quarterly total current liabilities has changed by -$4.46 M (-20.65%)